atropine has been researched along with doxazosin in 6 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (doxazosin) | Trials (doxazosin) | Recent Studies (post-2010) (doxazosin) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 1,372 | 439 | 283 |
| Protein | Taxonomy | atropine (IC50) | doxazosin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.544 | |
| Interstitial collagenase | Homo sapiens (human) | 5.749 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 2.748 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.2155 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0034 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.544 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.688 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.368 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0007 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.188 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.4022 | |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 2.2155 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Serels, S; Stein, M | 1 |
| Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M | 1 |
1 review(s) available for atropine and doxazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for atropine and doxazosin
| Article | Year |
|---|---|
Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Atropine; Cross-Over Studies; Delayed-Action Preparations; Doxazosin; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Prospective Studies; Safety; Severity of Illness Index; Treatment Outcome; Urinary Bladder; Urinary Incontinence; Urodynamics | 1998 |
4 other study(ies) available for atropine and doxazosin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates.
Topics: Adrenergic alpha-1 Receptor Antagonists; Atropine; Doxazosin; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; United Kingdom | 2013 |